Lymphocytes enable humans to fight and survive infections but are also major drivers of immune-mediated diseases, such as allergy and autoimmunity. These different types of immune responses are coordinated mostly by distinct CD4 + T cell subsets through signals delivered both by cytokines and by cell-to-cell contacts 1 . The developmental and differentiation programs of CD4 + T lymphocyte subsets with distinct effector functions have been extensively studied in terms of signaling pathways and transcriptional networks, and a certain degree of functional plasticity among different subsets has been established 2 . Indeed, flexibility of the CD4 + T cell subset in the expression of genes encoding cytokines and transcription factors allows the immune system to dynamically adapt to the many challenges it faces 3 . As CD4 + T lymphocyte subsets are no longer considered stable and terminally differentiated cell lineages, the question arises of how the phenotype and functions of lymphocytes can be modulated and whether such findings offer new therapeutic opportunities.
r e s o u r c e Lymphocytes enable humans to fight and survive infections but are also major drivers of immune-mediated diseases, such as allergy and autoimmunity. These different types of immune responses are coordinated mostly by distinct CD4 + T cell subsets through signals delivered both by cytokines and by cell-to-cell contacts 1 . The developmental and differentiation programs of CD4 + T lymphocyte subsets with distinct effector functions have been extensively studied in terms of signaling pathways and transcriptional networks, and a certain degree of functional plasticity among different subsets has been established 2 . Indeed, flexibility of the CD4 + T cell subset in the expression of genes encoding cytokines and transcription factors allows the immune system to dynamically adapt to the many challenges it faces 3 . As CD4 + T lymphocyte subsets are no longer considered stable and terminally differentiated cell lineages, the question arises of how the phenotype and functions of lymphocytes can be modulated and whether such findings offer new therapeutic opportunities.
In addition to the well-established role of transcription factors as instructive signals for cell differentiation toward a given lineage, other cues, such as epigenetic modifications, can regulate the maintenance of cellular states 4 . In this context, noncoding RNAs are emerging as a new regulatory layer that affects both the development of the immune system and its function 5, 6 . Among the several classes of noncoding RNAs with a specific role in lymphocyte biology, microRNAs are the best characterized [7] [8] [9] [10] [11] . Although thousands of long intergenic noncoding RNAs (lincRNAs) have been identified in the mammalian genome by bioinformatics analyses of transcriptomic data [12] [13] [14] , their functional characterization is still largely incomplete. The functional studies performed so far have shown that lincRNAs contribute to the control of cell differentiation and to the maintenance of cell identity through different modes of action 15 . Nuclear lincRNAs act mainly through their association with chromatin-modifying complexes [16] [17] [18] , whereas cytoplasmic lincRNAs can modulate translational control 19 and transcript stability 20 directly by base-pairing with specific targets or indirectly as competing endogenous RNAs [21] [22] [23] . A few examples of functional lincRNAs in the mouse immune system have been described. A broad analysis investigating naive and memory CD8 + cells purified from mouse spleen with a custom array of lincRNAs has reported the identification of 96 lymphoid-specific lincRNAs and has suggested a role for lincRNAs in the differentiation and activation of lymphocytes 24 . The lincRNA NeST has been found to be downregulated during lymphocyte activation in a manner reciprocal to the expression of interferon-γ (IFN-γ) and to control susceptibility to infection with Theiler's virus and salmonella in mice through epigenetic regulation of the Ifng locus 25, 26 . Subsequently, mouse lincRNA-Cox2 was reported to be induced downstream of signaling via Toll-like receptors and to mediate the activation and repression of distinct sets of genes that are targets of the immune system that encode molecules involved in inflammatory responses 27 . Another study of mouse thymocytes and mature peripheral T cells has allowed the identification of lincRNAs with specific expression patterns r e s o u r c e during T cell differentiation and of LincR-Ccr2-5′AS, a lincRNA specific to CD4 + T helper type 2 cells (T H 2 cells) that is involved in regulating the migration of CD4 + T H 2 lymphocytes 28 . Although such studies highlight the relevance of lincRNAs in regulating immune responses, a thorough analysis of their expression profile and function in the human immune system is still lacking.
The present study was based on the analysis of 13 highly purified primary human lymphocytes subsets by high-throughput sequencing technologies for cDNA (RNA-seq analysis). We performed de novo transcriptome reconstruction (the creation of a transcriptome without the aid of a reference genome) 29 and discovered over 500 previously unknown long intergenic noncoding RNAs (lincRNAs). We identified several lymphocyte subset-specific lincRNA signatures and found that expression of linc-MAF-4, a chromatin-associated, CD4 + T H 1 cell-specific lincRNA, correlated inversely with expression of the transcription factor c-Maf and that its downregulation skewed the differentiation of CD4 + T cells toward the T H 2 phenotype. We provide the first comprehensive inventory, to our knowledge, of human lymphocyte lincRNAs and demonstrate that lincRNAs can be key to lymphocyte differentiation. This resource will probably help in providing a better definition of the role of lincRNAs in the differentiation, plasticity and effector functions of lymphocytes.
RESULTS

Discrimination of human lymphocyte subsets by lincRNAs
To assess lincRNA expression in human primary lymphocytes, we extracted RNA from 13 lymphocyte cell subsets ( Table 1) purified from peripheral blood mononuclear cells from five healthy donors 11 . We then analyzed the polyadenylated RNA fraction by paired-end RNA sequencing and obtained about 1.7 × 10 9 mapped 'reads' . To enrich for transcripts derived from true active genes, we applied an expression threshold of 0.21 FPKM (fragments per kilobases of exons per million fragments mapped), defined through the integration of RNA-seq data and data on chromatin states from the ENCODE (Encyclopedia of DNA Elements) project 30 . We found a total of 31,902 expressed genes (including both protein-coding genes and noncoding genes) in the 13 subsets ( Table 1 and Supplementary Fig. 1a) , of which 4,201 were lincRNAs annotated in public resources 12, 31 (Fig. 1) . To identify previously unknown lincRNAs expressed in primary human lymphocytes, we used three de novo transcriptome-reconstruction strategies based on the combination of two different sequence mappers, TopHat and Star 32, 33 , with two different tools for de novo transcript assembly, Cufflinks and Trinity 34, 35 . We identified lincRNAs among the newly described transcripts by exploiting the following process. We selected transcripts that were longer than 200 nucleotides and multiexonic that did not overlap with proteincoding genes (and thus excluded unreliable single-exon fragments assembled by RNA-seq). We excluded transcripts with a conserved protein-coding region and those with open reading frames encoding protein domains catalogued in the Pfam database of protein families 36 . We used PhyloCSF, a comparative genomics method that assesses multispecies nucleotide-sequence alignment on the basis of a formal statistical comparison of phylogenetic codon models 37 , which efficiently identifies noncoding RNAs, as demonstrated by ribosomeprofiling experiments 38 . Finally, we defined a stringent new lincRNA set that included those genes for which at least one lincRNA isoform was reconstructed by two assemblers of three. Through this conservatively multilayered analysis we identified 563 previously unknown lincRNA-encoding genes, which increased by 11.8% the number of lincRNAs known to be expressed in human lymphocytes.
The various classes of RNAs were evenly distributed among various lymphocyte subsets ( Supplementary Fig. 1b) , and the ratio of already annotated and newly identified Fig. 1c ) and across various lymphocyte subsets (Supplementary Fig. 1d ).
As observed in various cell types 12, 34 , lincRNAs were also generally expressed at lower abundance than were protein-coding genes in human lymphocytes (Supplementary Fig. 1e ). However, when we categorized transcripts on the basis of their cell-specific expression and non-cell-specific expression (Supplementary Fig. 1f) , we found that cell-specific lincRNAs and cell-specific protein-coding genes displayed similar expression levels ( Supplementary Fig. 1e-g ).
Lymphocytes subsets display very different migratory abilities and effector functions, yet they are very closely related from the differentiation point of view. As lincRNAs are generally more tissue specific than are protein-coding genes 12, 39 , we assessed the lymphocyte cellsubset specificity of lincRNAs. We therefore classified genes according to their expression profiles by unsupervised K-means clustering and found that lincRNAs were defined by 15 clusters and protein-coding genes were defined by 24 clusters (Fig. 2a and Supplementary Fig. 2a) . Notably, the frequency of genes assigned to the clusters specific 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 6 7 8 9 npg r e s o u r c e for the various lymphocyte subsets was higher for lincRNAs (71%) than for proteincoding genes (34%) (Fig. 2b) . This superiority stood out even when we compared lincRNAs with genes encoding membrane receptors (40%) (Fig. 2c) , which are generally considered the most accurate markers of various lymphocyte subsets. We obtained similar results with the heuristic expression threshold of FPKM > 1 ( Supplementary  Fig. 2b ). Thus, by RNA-seq analyses of highly purified subsets of primary T lymphocytes and B lymphocytes, we were able to provide a comprehensive landscape of lincRNA expression in human lymphocytes. By exploiting de novo transcriptome reconstruction, we discovered 563 previously unknown lincRNAs and found that lincRNAs were effective in marking lymphocyte identity.
Identification of lincRNA signatures in lymphocytes
Next we investigated our data set for the presence of lincRNA signatures in the various lymphocyte subsets. We therefore looked for lincRNAs with a difference in expression of more than 2.5-fold in a given cell subset relative to their expression in all the other subsets (P < 0.05 (nonparametric Kruskal-Wallis test)) that were expressed in at least three of five donors and found 172 lincRNAs that met these criteria ( Fig. 3a and Supplementary Table 1) . We integrated the human transcriptome database with our newly identified transcripts and thus created a new reference with which to assess more thoroughly their expression in other human tissues. Assessing lincRNA signatures in a panel of 16 human tissues (from the Human BodyMap 2.0 project), we found that not only were lymphocyte signature lincRNAs expressed very poorly in nonlymphoid tissues but also most signature lincRNAs were not detectable even in lymphoid tissues (Fig. 3a,b) . These findings emphasized the importance of assessing the expression of lincRNAs (as well as of any highly cell-specific transcripts) in purified primary cells rather than in total tissues in which a given cell subset-specific transcript is diluted by the transcripts of all the other cell types of the tissue. We note that the newly identified lincRNAs defined as signatures were more abundant (Fig. 3c) and more cell specific (Supplementary Table 1 ) than the already annotated lincRNAs defined as signatures. We present here data obtained from the CD4 + T H 1 cell subset (Fig. 2b) ; we obtained similar results for all the other subsets (Supplementary Table 1) . Finally, to confirm and extend our signature data, we assessed expression of the signature lincRNAs of CD4 + T H 1 cells (Fig. 3b) by Expression z-score (Fig. 3d) . Moreover, 90% of the CD4 + T H 1 cell signature lincRNAs that were expressed in resting CD4 + T H 1 cells purified ex vivo also had high expression in naive CD4 + T cells differentiated under T H 1-polarizing conditions in vitro, whereas they had low expression in naive CD4 + T cells differentiated toward the T H 2 phenotype in vitro (Fig. 3e) . As a corollary to those findings, we observed by RNA-seq that the signature lincRNAs of CD4 + naive cells were mostly downregulated during differentiation toward the T H 0 phenotype in vitro, whereas the signature lincRNAs of cells of the T H 1, T H 2 and T H 17 subsets of helper T cells were mostly upregulated ( Supplementary  Fig. 3a) . Together our data demonstrated that lincRNAs provided signatures of human lymphocyte subsets and suggested that human CD4 + T lymphocytes acquired most of their memory-specific lincRNA signatures during their activation-driven differentiation from naive cells to memory cells.
Downregulation of linc-MAF-4 skews CD4 + T cells toward T H 2 cells
As lincRNAs have been reported to influence the expression of neighboring genes 25, 26, 28, 40 , we sought to determine whether protein-coding genes proximal to the signature lincRNAs of lymphocytes were involved in key cell functions. For this we used the FatiGO tool from the Babelomics suite for functional enrichment analysis 41 r e s o u r c e protein-coding genes adjacent to signature lincRNAs showed enrichment for gene ontology terms correlated with the activation of lymphocyte T cells (Fig. 4) , which indicated a possible role for signature lincRNAs in lymphocyte function. To obtain proof of concept of this hypothesis, we chose to characterize in depth linc-MAF-4 (lnc-MAF-2 in the LNCipedia database 42 ), a signature lincRNA of T H 1 cells located 139.5 kilobases upstream of MAF. This gene encodes transcription factor c-Maf, which is involved in T H 2 differentiation 43 but is also required for the efficient development of T H 17 cells 44 and controls transcription of the gene encoding interleukin 4 in CD4 + follicular helper T cells 45 . Our sequencing data showed that high expression of linc-MAF-4 correlated with a low abundance of MAF transcripts in CD4 + T H 1 cells; conversely, T H 2 cells had low expression of linc-MAF-4 and abundant MAF transcripts (data not shown). The anti-correlation of expression between lincRNAs and their neighboring genes is not a common feature of all lincRNAs 12, 16 and is probably restricted to a limited number of cis-acting lincRNAs. We also confirmed this observation in our data set (data not shown). Moreover, we observed no correlation between the expression of linc-MAF-4 and its proximal upstream proteincoding genes CDYL2 and DYNLRB2 (Supplementary Fig. 4a) .
We observed a similar inverse relation between linc-MAF-4 and MAF when we differentiated naive CD4 + T cells in vitro toward the T H 1 or T H 2 phenotype. In T lymphocytes differentiating toward the T H 1 phenotype, MAF transcripts increased up to day 3 and then decreased thereafter (Fig. 5a) . Conversely, linc-MAF-4 was poorly expressed for the first 3 d but then increased progressively (Fig. 5a) . In CD4 + T lymphocytes differentiating toward the T H 2 phenotype, the abundance of both MAF transcripts and c-Maf protein increased constantly up to day 8, while Iinc-MAF-4 remained constantly low ( Fig. 5a and Supplementary Fig. 4c) , similar to what we observed for CD4 + T lymphocytes differentiating toward the T H 17 phenotype (Supplementary Fig. 4d) .
We further characterized the transcriptional regulation of MAF by assessing the abundance of histone H3 trimethylated at Lys4 (H3K4me3) and occupancy by RNA polymerase II at the MAF promoter region in T H 1 and T H 2 cells. Consistent with the higher active transcription of MAF in CD4 + T H 2 cells, we found enrichment for H3K4me3 in T H 2 cells relative to its abundance in T H 1 cells and that binding of RNA polymerase II at MAF promoter was higher in T H 2 than in T H 1 cells (Fig. 5b) . Notably, knockdown of linc-MAF-4 in activated CD4 + naive T cells led to increased MAF expression ( Fig. 5c and Supplementary Fig. 4e ). All the results presented above indicated that modulation of MAF transcription in T cells depended on tuning of its promoter setting, and suggested direct involvement of linc-MAF-4 in the regulation of MAF transcription.
We then assessed the overall effect of the knockdown of linc-MAF-4 on the differentiation of CD4 + T cells by transcriptome profiling npg r e s o u r c e and gene set-enrichment analysis. We defined as reference gene sets the groups of genes upregulated in CD4 + naive T cells differentiated in vitro toward the T H 1 or T H 2 phenotype (Supplementary Table 2) . We found that the CD4 + T H 2 cell gene set showed enrichment for genes overexpressed in cells in which linc-MAF-4 was knocked down, whereas the CD4 + T H 1 cell gene set showed depletion of those same genes (Fig. 5d) . Concordant with those findings, the expression of GATA3 and IL4, two genes characteristic of T H 2 cells, was increased after knockdown of linc-MAF-4 ( Fig. 5e and Supplementary  Fig. 4f ). Together these results demonstrated that downregulation of linc-MAF-4 contributed to skewing of the differentiation of CD4 + T cells toward the T H 2 phenotype.
Epigenetic regulation of MAF transcription by linc-MAF-4
Since the gene encoding linc-MAF-4 maps in relative proximity to MAF (within 139.5 kilobases), we sought to determine whether linc-MAF-4 was able to downregulate MAF transcription, and we investigated whether their genomic regions could physically interact. We exploited chromosome-conformation capture analysis to determine the relative crosslinking frequencies among regions of interest.
We assessed the conformation of the genomic regions of the gene encoding linc-MAF-4 (called 'linc-MAF-4' here) and MAF in differentiated CD4 + T H 1 cells. We used common reverse-primer mapping of the MAF promoter region in combination with a set of primers spanning the locus and analyzed interactions by PCR. We detected specific interactions between the MAF promoter and the 5′ and 3′ end regions of linc-MAF-4 ( Fig. 6a and Supplementary Fig. 5a,b) , which indicated the existence of an in cis chromatin-looping conformation that brought linc-MAF-4 in close proximity to the MAF promoter. Notably, subcellular fractionation of CD4 + T H 1 lymphocytes differentiated in vitro revealed considerable enrichment for linc-MAF-4 in the chromatin fraction (Fig. 6b) . Because other chromatin-associated lincRNAs regulate neighboring genes by recruiting specific chromatin remodelers, we assessed by RNA-immunoprecipitation assay the interaction of linc-MAF-4 with various chromatin modifiers, including activators and repressors (data not shown), and found specific enrichment for linc-MAF-4 in the immunoprecipitates of two chromatin modifiers, EZH2 and LSD1 (Fig. 6c and Supplementary Fig. 5c ). In agreement with those findings, we found that knockdown of linc-MAF-4 in activated CD4 + naive T cells reduced the abundance of both EZH2 and LSD1 and correlated with lower enzymatic activity of EZH2 at the MAF promoter, as demonstrated by a lower abundance of H3K27me3 at this locus (Fig. 6d) . Notably, the content of H3K27me3 was not diminished at either the MYOD1 promoter region (a known target of EZH2) or at a region within the chromatin loop between linc-MAF-4 and MAF marked by H3K27me3 ( Supplementary  Fig. 5d ). Together these results demonstrated a long-distance interaction between the genomic regions of linc-MAF-4 and MAF, through which linc-MAF-4 might act as a scaffold to recruit both EZH2 and LSD1 and modulate the enzymatic activity of EZH2 on the MAF promoter and thus regulate its transcription (Fig. 6e) .
DISCUSSION
Mammalian genomes encode more long noncoding RNAs than initially thought 16, 46 , and the identification of lincRNAs with a role in cellular processes is growing steadily. As there are relatively few examples of functional long noncoding RNAs in the immune system [24] [25] [26] [27] [28] , with the present study we have presented a comprehensive landscape of the expression of lincRNAs in 13 subsets of human primary lymphocytes. Moreover, we have identified a lincRNA (linc-MAF-4) that seemed to have a key role in the differentiation of CD4 + helper T cells.
LincRNAs have been reported to have high tissue specificity 12 , and our study of lincRNA expression in highly pure primary human lymphocyte has provided added value because it allowed the identification of lincRNAs whose expression was restricted to a given lymphocyte cell subset. Notably, we found that lincRNAs defined cellular identity better than protein-coding genes did, including those that encode surface receptors that are generally considered the most precise markers of lymphocyte subsets. Due to their specificity of expression, human lymphocyte lincRNAs that are not yet annotated in public resources would have not been identified without de novo transcriptome reconstruction. Indeed, by exploiting three different de novo strategies, we identified 563 previously unknown lincRNAs and increased by 11.8% the number of lincRNAs known to be expressed in human lymphocytes. As our conservative analysis was limited to 13 cellular subsets, it remains unclear how many novel lincRNAs could be identified by transcriptome analysis of all of the several hundreds of human cell types.
We compared our data with published analyses of lincRNA expression in the mouse immune system 28 , exploiting the LNCipedia database 42 . We found that 51% of the human lincRNA signature was conserved in mice, which is similar to the overall conservation between human lincRNAs and mouse lincRNAs (60%). However, further studies will be needed to assess whether their function is also conserved.
Given our findings, signature lincRNAs might be exploited to discriminate and differentiate at the molecular level those cell subsets that cannot be distinguished easily on the basis of cell surface markers because of their cellular heterogeneity, such as CD4 + regulatory T cells. However, as lincRNA expression in a tissue is averaged across all the cell types that compose that tissue, transcriptome analysis of unfractionated tissue-derived cells may underestimate the expression of cell-specific lincRNAs. In fact, the great majority of our lymphocyte lincRNA signatures could not be detected among RNA extracted from total lymphoid tissues (peripheral blood and lymph nodes), although these same tissues contained cells from all of the lymphocytes subsets we assessed.
The role of lincRNAs in differentiation has been described for various cell types 17, 20, 23, 47, 48 . In the mouse immune system, it has been found that lincRNA expression changes during the differentiation of naive CD8 + T cells into memory CD8 + T cells 24 and during the differentiation of naive CD4 + T cells into distinct lineages of helper T cells 28 . We have shown for human primary lymphocytes that activation-induced differentiation of CD4 + naive T cells was associated with increased expression of lincRNAs belonging to the CD4 + T H 1 cell signature, which suggests that upregulation of T H 1 cell lincRNAs is part of the cell-differentiation transcriptional program. Indeed, linc-MAF-4, one of the T H 1 cell signature lincRNAs, had low expression in T H 2 cells, and its experimental downregulation skewed differentiating helper T cells toward a T H 2 transcription profile. We found that linc-MAF-4 regulated transcription by exploiting a chromosome loop that brought its genomic region close to the promoter of MAF. We propose that the chromosome organization of this region allows a linc-MAF-4 transcript to recruit both EZH2 and LSD1 and to modulate the enzymatic activity of EZH2 that negatively regulates MAF transcription via a mechanism of action similar to that shown for the lincRNAs HOTAIR 49 and MEG3 (ref. 50) . We therefore have provided mechanistic proof of the concept that lincRNAs can be important regulators of CD4 + T cell differentiation. Given the number of specific lincRNAs expressed in various lymphocyte subsets, it can be postulated that many other lincRNAs might contribute to cell differentiation and to the definition of identity in human npg lymphocytes. These findings and the high cell specificity of lincRNAs suggest that lincRNAs might be highly specific molecular targets for the development of new therapies for diseases (such as autoimmunity, allergy and cancer) in which altered CD4 + T cell functions have a pathogenic role. 
METHODS
Methods
ONLINE METHODS
Purification of primary immunological cell subsets. Blood buffy coat cells of healthy donors were obtained from Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca'Granda Ospedale Maggiore Policlinico in Milan, and peripheral blood mononuclear cells were isolated by ficoll-hypaque densitygradient centrifugation. The ethical committee of Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca'Granda Ospedale Maggiore Policlinico approved the use of peripheral blood mononuclear cells from healthy donors for research purposes, and informed consent was obtained from subjects. Human blood primary lymphocyte subsets were purified to a purity of >95% by cell sorting through the use of various combinations of surface markers ( Table 1) . For in vitro differentiation experiments, resting naive CD4 + T cells were purified to a purity of >95% by negative selection with magnetic beads with an isolation kit for human CD4 + Naive T cells (Miltenyi) and were stimulated with Dynabeads Human T-Activator CD3/CD28 (Life Technologies). Interleukin 2 (IL-2) was added at 20 IU/ml (202-IL; R&D Systems). T H 1 polarization was initiated with 10 ng/ml IL-12 (219-IL; R&D Systems) and T H 2-neutralizing antibody anti-IL-4 (2 µg/ml; MAB3007; R&D Systems). T H 2 polarization was induced by activation with phytohemagglutinin (4 µg/ml; L2769; Sigma) in the presence of IL-4 (10 ng/ml; 204-IL; R&D Systems), and neutralizing anti-IFN-γ (2 µg/ml; MAB 285; R&D Systems) and anti-IL-12 (2 µg/ml; MAB219; R&D Systems). For intracellular staining of GATA-3 and c-Maf, cells were harvested and then were fixed for 30 min at 4 °C in Fixation/Permeabilization Buffer (eBioscience). Cells were stained for 30 min at 4 °C with anti-GATA-3 (TWAJ; eBioscience) and anti-c-Maf (sym0F1; eBioscience) in washing buffer. Cells were then washed two times, resuspended in autoMACS buffer (Miltenyi) and analyzed by flow cytometry.
RNA isolation and RNA sequencing. Total RNA was isolated with an mirVana Isolation Kit. Libraries for Illumina sequencing were constructed from 100 ng of total RNA with the Illumina TruSeq RNA Sample Preparation Kit v2 (Set A). The libraries generated were loaded on to the cBot automated clonal amplification system (Illumina) for clustering on a HiSeq Flow Cell v3. The libriaries clustered on a HiSeq Flow Cell v3 were then sequenced with a HiScanSQ optical imaging system (Illumina). A paired-end run (with a read length of 101 bases) was performed with an SBS Kit v3 DNA sequencing kit (Illumina). Real-time analysis and base calling was performed with HiSeq Control Software Version 1.5 (Illumina).
RNA-seq. RNA-seq data representative of 13 lymphocyte populations were collected for transcriptome reconstruction. Five biological replicates were analyzed for all populations except for CD8 + T CM cells and CD5 + B cells (four samples). The whole data set was aligned to human genome assembly GRCh37 (Genome Reference Consortium Human Build 37) with TopHat software (version 1.4.1) 33 for a total of over 1.7 × 10 9 mapped paired-end reads (30 million reads per sample on average). These data were also mapped with the aligner STAR (version 2.2.0) 32 . RNA-seq data sets of 16 human tissues belonging to the Illumina Human BodyMap 2.0 project (ArrayExpress accession code E-MTAB-513) were mapped according to the same criteria.
Reference annotation. An initial custom reference annotation of unique, non-redundant transcripts was built by integration of the Ensembl database (version 67 from May 2012) with the lincRNAs identified by another group 13 through the use of the Cuffcompare tool (version 2.1.1) of the Cufflinks suite 34 . The annotated human lincRNAs were extracted from Ensembl through the use of the BioMart software suite (version 67) and were categorized by gene biotype 'lincRNA' (5,804 genes). Other classes of genes were integrated in the annotation: the list of protein-coding genes (21,976 genes), the collection of receptor-encoding genes defined in BioMart under GO term GO:000487 (2,043 genes encoding molecules with receptor activity function) and the class of genes encoding molecules involved in metabolic processes corresponding to GO term GO:0008152 (7,756 genes). Hence, the complete reference annotation consisted of 195,392 transcripts that referred to 62,641 genes, 11,170 of which were nonredundant lincRNA-encoding genes.
De novo genome-based transcripts reconstruction. A comprehensive catalog of lincRNAs specifically expressed in human lymphocyte subsets was generated with a de novo genome-based transcripts reconstruction procedure by three different approaches. Two aligners were used: TopHat (version 1.4.1) and STAR (version 2.2.0). The de novo transcriptome assembly was performed on the aligned sequences (samples of the same population were concatenated into one 'population alignment') generated by STAR and TopHat using Cufflinks (version 2.1.1) with reference annotation to guide the assembly (-g option) coupled with multi-read (-u option) and fragment-bias correction (-b option) to improve the accuracy with which transcript abundance was estimated. By this method, about 3 × 10 4 to 5 × 10 4 previously unknown transcripts were identified in each lymphocyte population. The third approach used genome-guided Trinity software (additional information available at http://pasa.sourceforge. net/#A_ComprehensiveTranscriptome), which generates novel transcripts by local assembly on previously mapped reads from specific location. STAR was used instead of the Trinity default aligner 29 . Each candidate transcript was then processed via the PASA 'pipeline' (Program to Assemble Spliced Alignments; a genome annotation tool), which reconstructs the complete transcript and gene structures, resolving incongruences derived from transcript misalignments and alternatively splices events, refining the reference annotation when there was enough evidence and proposing new transcripts and genes in case no previous annotation was able to explain the new data (Supplementary Note).
Identification of previously unknown lincRNA-encoding genes. Annotated transcripts and previously unknown isoforms of known genes were discarded, and only previously unknown genes and their isoforms located in intergenic positions were retained. To filter out artifactual transcripts due to transcriptional noise or low polymerase fidelity, only multi-exonic transcripts longer than 200 bases were retained. Then, the HMMER3 algorithm 36 was run for each transcript to identify occurrences of any protein family domain documented in the Pfam database (release 26; both PfamA and PfamB were used). All six possible frames were considered for the analysis, and the matching transcripts were excluded from the final catalog.
The coding potential for all the remaining transcripts was then evaluated by the PhyloCSF comparative genomics method (phylogenetic codon substitution frequency) 37 , which was run on a multiple sequence alignment of 29 mammalian genomes (in multi-alignment file (MAF) format) (http://hgdownload.cse. ucsc.edu/goldenPath/hg19/multiz46way/) to obtain the open reading frames that encoded proteins of over 29 amino acids in length across all three reading frames and had the best scores. For efficient accessing of the MAFs, the biogem plugin of the bio-maf Ruby (MAF parser for the BioRuby open-source bioinformatics library for Ruby programming code; https://github.com/csw/ bioruby-maf) 51 was used. This library provides indexed and sequential access to MAF data, and also performs fast manipulations on it and writes modified MAFs. Transcripts with at least one open reading frame with a PhyloCSF score of over 100 were excluded from the final catalog. The threshold of 100 for the PhyloCSF score was determined as described 13 to optimize specificity and sensitivity for the classification of coding and noncoding transcripts annotated in the RefSeq reference sequence database of the National Center for Biotechnology Information (RefSeq coding and RefSeq lincRNAs). A PhyloCSF score of 100 corresponds to a false-negative rate of 6% for coding genes (i.e., 6% of coding genes are classified as noncoding) and a false-positive rate of ~10% (i.e., 9.5% of noncoding transcripts are classified as coding).
De novo transcriptome data integration. Duplicates among the transcripts identified with the same de novo method were resolved through the use of Cuffcompare (version 2.1.1). In the same way, the resulting three data sets were further merged to generate a nonredundant atlas of lincRNAs in human lymphocytes and only those genes identified by at least two of the three software programs used were considered. A unique name was given to each newly identified lincRNA gene composed by the prefix 'linc-' followed by the Ensembl gene name of the nearest protein-coding gene (irrespective of the strand). The additional designation 'up' or 'down' defines the location of the lincRNA relative to the sense of transcription of the nearest protein-coding gene. In addition, either 'sense' or 'antisense' was added to describe the concordance of transcription between the lincRNA and its nearest coding gene. A numerical counter only of newly identified lincRNAs related to the same protein-coding gene is added as suffix (such as 'linc-geneX-(up|down)-(sense|antisense)_#n'). This final nonredundant
